Clinical trial · Observational
Survey Based Discrete Choice Experiment Study in Prostate Cancer (DECIDER) Study
Prospective Evaluation of Patient Preferences for Outcomes of Hormonal Agents and Chemotherapy in Combination With Androgen Deprivation Therapy
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to quantify and publish participants' relative preferences for outcomes of chemotherapy and novel oral hormonal agents when added to androgen deprivation therapy (ADT) for participants with locally-advanced and metastatic hormone-sensitive prostate cancer (mHSPC). This study will also quantify the importance of administration factors related to convenience relative to treatment outcomes.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Metastatic Hormone-sensitive Prostate Cancer | — | UNRESOLVED | — |
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Log-odds (preference weights) by participant cancer type and country
- timeFrame
- 1 day (once through survey)
- description
- Log-odds indicate participants' relative preferences for treatments with each attribute level in the study, all else equal.
Secondary outcomes (1)
- measure
- Relative importance weights by participant type and country
- timeFrame
- 1 day (once through survey)
- description
- These weights indicate the overall influence of each study attribute on choice.
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: For interviews (attribute prioritization and pretest interviews) * Diagnosis of mHSPC with or without previous experience with ADT * Able to read and understand the survey language * Able to provide informed consent For online survey * Diagnosis of mHSPC or locally-advanced prostate cancer with or without previous experience with ADT * Able to read and understand the survey language * Able to provide informed consent Exclusion Criteria: Not applicable
References
Publications (0)
Data not yet available